<DOC>
	<DOCNO>NCT00983801</DOCNO>
	<brief_summary>The purpose study determine whether ixabepilone effective treatment unresectable metastatic gastric cancer Asian participant .</brief_summary>
	<brief_title>Study Ixabepilone Asian Subjects With Unresectable Metastatic Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Epothilones</mesh_term>
	<criteria>Histologically confirm gastric carcinoma originate stomach gastroesophageal junction Must unresectable metastatic disease Asian ethnicity Must fail prior fluoropyrimidinebased chemotherapy Eastern Cooperative Oncology Group ( ECOG ) performance status 01 measurable disease Response Evaluation Criteria Solid Tumors ( RECIST ) guideline &gt; 1 prior chemotherapy regimen metastatic set &gt; 2 prior chemotherapy subject also receive adjuvant therapy Receipt prior ixabepilone ECOG ≥2 Known brain meningeal metastasis Known viral hepatitis Prior taxane therapy Uncontrolled noncancer relate medical condition Second malignancy Peripheral neuropathy ≥ grade 2 Inadequate hematologic , renal hepatic function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>